Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis

References

• Khalid A, Ali S. COVID-19 and its challenges for the healthcare system in Pakistan. Asian Bioeth Rev. 2020 Dec;12(4):551–564.
   PubMedGoogle Scholar
• Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941.
   PubMed Web of Science ®Google Scholar
• Xie X, Zhong Z, Zhao W, et al. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 2020:200343.
   PubMed Web of Science ®Google Scholar
• Li D, Wang D, Dong J, et al. False-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2: role of deep-learning-based CT diagnosis and insights from two cases. Korean J Radiol. 2020;21(4):505.
   PubMed Web of Science ®Google Scholar
• Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020 Aug;296(2):E32–E40.
   PubMed Web of Science ®Google Scholar
• Di Gennaro F, Pizzol D, Marotta C, et al. Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review. Int J Environ Res Public Health. 2020 Apr 14;17(8):2690. DOI:https://doi.org/10.3390/ijerph17082690.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang R, He G. Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann Hematol. 2020 Jul;99(7):1421–1428.
   PubMed Web of Science ®Google Scholar
• Protocol on prevention and control of COVID-19 (Edition 6) [Internet]. [cited 2021 Mar 20]. Available from: http://en.nhc.gov.cn/2020-03/29/c_78468.htm.
   Google Scholar
• Wang R, Hozumi Y, Yin C, et al. Mutations on COVID-19 diagnostic targets. Genomics. 2020;112(6):5204–5213.
   PubMed Web of Science ®Google Scholar
• Aktas G. A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection. Exp Biomed Res. 2020 Oct 1;3(4):293–311.
   Google Scholar
• National Health Commission of the PRC [Internet]. [cited 2021 Mar 20]. Available from: http://en.nhc.gov.cn/.
   Google Scholar
• Sato H, Tsubosa Y, Kawano T. Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer. World J Surg. 2012 Mar;36(3):617–622.
   PubMed Web of Science ®Google Scholar
• Martins EC, da Silveira LF, Viegas K, et al. Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study. Rev Bras Ter Intensiva. 2019;31(1):63–70.
   Google Scholar
• Certain medical conditions and risk for severe COVID-19 illness CDC [Internet]. [cited 2021 Jun 29]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.
   Google Scholar
• Lattanzi S, Cagnetti C, Provinciali L, et al. Neutrophil-to-lymphocyte ratio and neurological deterioration following acute cerebral hemorrhage. Oncotarget. 2017 Aug 22;8(34):57489–57494.
   PubMedGoogle Scholar
• Duman TT, Aktas G, Atak BM, et al. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019 Apr 18;19(1):1602.
   PubMed Web of Science ®Google Scholar
• Świtońska M, Piekuś-Słomka N, Słomka A, et al. Neutrophil-to-lymphocyte ratio and symptomatic hemorrhagic transformation in Ischemic stroke patients undergoing revascularization. Brain Sci. 2020;10(11):771. DOI:https://doi.org/10.3390/brainsci10110771.
   PubMed Web of Science ®Google Scholar
• Aktas G, Duman T, Atak B, et al. Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters. Fam Med Prim Care Rev. 2020;22(2):107–110.
   Web of Science ®Google Scholar
• Simadibrata DM, Pandhita BAW, Ananta ME, et al. Platelet-to-lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: a systematic review and meta-analysis. J Intensive Care Soc. 2020: 1–7. DOI:https://doi.org/10.1177/1751143720969587.
   Google Scholar
• Qu R, Ling Y, Zhang Y-H-Z, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020 Sep;92(9):1533–1541.
   PubMed Web of Science ®Google Scholar
• Waris A, Din M, Khalid A, et al. Evaluation of hematological parameters as an indicator of disease severity in covid-19 patients: Pakistan’s experience. J Clin Lab Anal. 2021;35(6):e23809. DOI:https://doi.org/10.1002/jcla.23809.
   PubMed Web of Science ®Google Scholar
• Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499.
   PubMed Web of Science ®Google Scholar
• Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31.
   PubMed Web of Science ®Google Scholar
• Korevaar DA, Cohen JF, Reitsma JB, et al. Updating standards for reporting diagnostic accuracy: the development of STARD 2015. Res Integr Peer Rev. 2016 Dec;1(1):7.
   PubMedGoogle Scholar
• Miller IF, Becker AD, Grenfell BT, et al. Disease and healthcare burden of COVID-19 in the United States. Nat Med. 2020 Aug;26(8):1212–1217.
   PubMed Web of Science ®Google Scholar
• Barger AM. The complete blood cell count: a powerful diagnostic tool. Vet Clin Small Anim Pract. 2003;33(6):1207–1222.
   PubMed Web of Science ®Google Scholar
• Xu P, Tian R, Luo S, et al. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study. Theranostics. 2020;10(14):6372–6383.
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–273.
   PubMed Web of Science ®Google Scholar
• Weinkove R, McQuilten ZK, Adler J, et al. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. Med J Aust. 2020 Jun;212(10):481–489.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• CDC. Healthcare workers [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2021 Jun 29]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html.
   Google Scholar
• Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):1–5.
   PubMed Web of Science ®Google Scholar
• Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020;9(1):687–690.
   PubMed Web of Science ®Google Scholar
• Yang A-P, Liu J-P, Tao W-Q, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504.
   PubMed Web of Science ®Google Scholar
• Gong J, Ou J, Qiu X, et al. A tool for early prediction of severe coronavirus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clin Infect Dis. 2020;71(15):833–840. DOI:https://doi.org/10.1093/cid/ciaa443..
   PubMed Web of Science ®Google Scholar
• Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020 Jul 28;71(15):762–768.
   PubMed Web of Science ®Google Scholar
• Fischer K, Hoffmann P, Voelkl S, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007;109(9):3812–3819.
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934–943.
   PubMed Web of Science ®Google Scholar
• Sit M, Aktas G, Erkol H, et al. Neutrophil to lymphocyte ratio is useful in differentiation of malign and benign thyroid nodules. P R Health Sci J. 2019;38(1):60–63.
   PubMed Web of Science ®Google Scholar
• Aktas G, Duman TT, Kurtkulagi O, et al. Liver steatosis is associated both with platelet distribution width, neutrophil/lymphocyte and monocyte/lymphocyte ratios. Prim Health Care Open Access. 2020;10(4):1–4.
   Google Scholar
• Chan AS, Rout A. Use of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19. J Clin Med Res. 2020 Jul;12(7):448–453.
   PubMedGoogle Scholar
• Zeng F, Li L, Zeng J, et al. Can we predict the severity of coronavirus disease 2019 with a routine blood test? Pol Arch Intern Med. 2020;130(5):400–406. DOI:https://doi.org/10.20452/pamw.15331.
   PubMedGoogle Scholar
• Ghahramani S, Tabrizi R, Lankarani KB, et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020 Aug 3;25(1):30.
   PubMed Web of Science ®Google Scholar
• Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol. 2020;92(10):1733–1734.
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost JTH. 2020 Apr;18(4):844–847.
   PubMed Web of Science ®Google Scholar
• Huang I, Pranata R, Lim MA, et al. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020;14:1753466620937175.
   Web of Science ®Google Scholar
• Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020 Jul;95(7):834–847.
   PubMed Web of Science ®Google Scholar
• Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748–773.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study. Platelets. 2020 May 18;31(4):490–496.
   PubMed Web of Science ®Google Scholar
• Wang L, He W-B, Yu X-M, et al. Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients. World J Clin Cases. 2020;8(19):4370.
   PubMed Web of Science ®Google Scholar
• Linkins L, Takach Lapner S. Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol. 2017;39:98–103.
   PubMed Web of Science ®Google Scholar
• Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020 Sep 1;7(9):e671–e678.
   PubMed Web of Science ®Google Scholar
• Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023–1026.
   PubMed Web of Science ®Google Scholar
• Asghar MS, Khan NA, Haider Kazmi SJ, et al. Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis. J Community Hosp Intern Med Perspect. 2020 Oct;10(6):514–520.
   PubMed Web of Science ®Google Scholar
• Paranjpe I, Fuster V, Lala A, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020;76(1):122–124.
   PubMed Web of Science ®Google Scholar
• Yao Y, Cao J, Wang Q, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020 Dec;8(1):49.
   PubMed Web of Science ®Google Scholar